Mapping lung squamous cell carcinoma pathogenesis through in vitro and in vivo models
Gómez-López and co-authors discuss advances in the development of in vitro and in vivo models for lung squamous cell carcinoma (LUSC) and their role in understanding the cellular and molecular processes driving LUSC development and responses to therapy.
Guardado en:
Autores principales: | Sandra Gómez-López, Zoe E. Whiteman, Sam M. Janes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d936ce2a63244909d5cd1039e1cd7e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model
por: Omchit Surien, et al.
Publicado: (2021) -
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
por: Vavalà T
Publicado: (2017) -
In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
por: Guilherme Ribeiro Romualdo, et al.
Publicado: (2021) -
NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model
por: Muhammad Asyaari Zakaria, et al.
Publicado: (2021) -
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Na Li, et al.
Publicado: (2021)